The global hypnotic and sedative medicine market in 2024 highlights Canada leading with $152.3 million in sales, followed by Belgium and South Korea. The year-on-year variation in 2023 showed South Korea with a significant increase of 12.37%, while Italy and New Zealand also exhibited notable growth of 6.85% and 17.75%, respectively. Over five years, the compound annual growth rate (CAGR) reflects a consistent upward trend in the market, indicating robust demand, particularly in Asia and Europe.
Future trends to watch include growing adoption in emerging markets, regulatory changes, and advancements in pharmaceutical technology that could introduce new products to expand the market further globally.
Top countries in Hypnotic and Sedative Medicine Sales by Country
| # | 10 Countries | Million US Dollars PPP | Last Year | YoY | 5-years CAGR | |
|---|---|---|---|---|---|---|
| 1 | 1 Canada | 152.3 | 2023 | -5.64% | +0.45% | View data |
| 2 | 2 Belgium | 104.6 | 2023 | +1.45% | +1.63% | View data |
| 3 | 3 South Korea | 103.9 | 2023 | +5.91% | +12.37% | View data |
| 4 | 4 Croatia | 98 | 2023 | +3.92% | +3.08% | View data |
| 5 | 5 Sweden | 78.3 | 2023 | +2.35% | +2.68% | View data |
| 6 | 6 Italy | 24.1 | 2023 | +73.38% | +6.85% | View data |
| 7 | 7 Ireland | 23 | 2023 | 0% | +0.26% | View data |
| 8 | 8 Denmark | 16.9 | 2023 | +1.81% | +1.74% | View data |
| 9 | 9 Slovakia | 15 | 2023 | +4.17% | +3.55% | View data |
| 10 | 10 New Zealand | 4.3 | 2023 | +2.38% | +17.75% | View data |
